The new weekly 120mg SC formulation, supported by TULIP-SC trial results, offers patients with moderate to severe SLE a self-administered alternative to monthly IV infusions.
Please provide your email address to receive an email when new articles are posted on . Eylea HD allowed for longer treatment intervals compared with Eylea and showed similar safety and efficacy.
Rusfertide may reduce phlebotomy needs in polycythemia vera, offering a convenient weekly self-injection option that could ...
A new white paper entitled "Inside the Science: A Major Step Forward for Knee Osteoarthritis" has been released which heralds the dawn of a new era of treatments for knee osteoarthritis (OA) that can ...
NEEDHAM, Mass., Oct. 9, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a commercial-stage biotechnology company focused on the discovery, development and ...
The Louisiana Department of Public Health (LDH) is reminding the public to take precautions before receiving injections of botulinum toxin, commonly referred to as botox, and to avoid receiving ...
BATON ROUGE, La. (KLFY) – The Louisiana Department of Public Health (LDH) is reminding the public to take precautions before receiving injections of botulinum toxin, commonly referred to as botox, and ...
This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results